Cargando…
Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis
The proteasome inhibitor, bortezomib, is ineffective against many solid tumors. Nutlin-3 is a potent antagonist of human homolog of murine double minute 2/p53 interaction exhibiting promising therapeutic anti-cancer activity. In this study, we show that treatment of various p53-defective bortezomib-...
Autores principales: | Lee, Dong Min, Kim, In Young, Seo, Min Ji, Kwon, Mi Ri, Choi, Kyeong Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579507/ https://www.ncbi.nlm.nih.gov/pubmed/28798402 http://dx.doi.org/10.1038/emm.2017.112 |
Ejemplares similares
-
Intracellular Ca(2 +) Imbalance Critically Contributes to Paraptosis
por: Kim, Eunhee, et al.
Publicado: (2021) -
Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells
por: Seo, Min Ji, et al.
Publicado: (2023) -
PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca(2+) Imbalance
por: Lee, Hong-Jae, et al.
Publicado: (2022) -
RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis
por: Kim, Jin Yeop, et al.
Publicado: (2019) -
Awakening p53 in senescent cells using nutlin-3
por: Schug, Thaddeus T.
Publicado: (2009)